Brian M Strem's most recent trade in Kiora Pharmaceuticals Inc was a trade of 1,906 Common Stock done at an average price of $2.0 . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiora Pharma Inc | Brian M. Strem | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.95 per share. | 01 Apr 2026 | 1,906 | 60,692 (1%) | 0% | 2.0 | 3,717 | Common Stock |
| Kiora Pharma Inc | Brian M. Strem | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 33,467 | 33,467 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Brian M. Strem | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 16,733 | 62,598 (1%) | 0% | 0 | Common Stock | |
| Kiora Pharma Inc | Brian M. Strem | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 31,883 | 31,883 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Brian M. Strem | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 15,941 | 46,103 (0%) | 0% | 0 | Common Stock | |
| Kiora Pharma Inc | Brian M. Strem | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 31,259 | 31,259 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Brian M. Strem | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 15,629 | 30,160 (0%) | 0% | 0 | Common Stock | |
| Kiora Pharma Inc | Brian M. Strem | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 13 Jun 2024 | 3,000 | 14,531 (0%) | 0% | 5.0 | 14,997 | Common Stock |
| Kiora Pharma Inc | Brian M. Strem | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 3.83 per share. | 03 Mar 2023 | 15,600 | 28,783 (0%) | 0% | 3.8 | 59,748 | Common Stock |
| Kiora Pharma Inc | Brian M. Strem | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 10,400 | 10,400 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Brian M. Strem | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2022 | 18,750 | 18,750 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Brian M. Strem | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2022 | 12,500 | 13,183 (0%) | 0% | 0 | Common Stock | |
| Kiora Pharma Inc | Brian M. Strem | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Brian M. Strem | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.41 per share. | 21 Oct 2021 | 17,853 | 27,370 (0%) | 0% | 1.4 | 25,173 | Common Stock |
| Kiora Pharma Inc | Brian M. Strem | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2021 | 9,517 | 9,517 (0%) | 0% | - | Common Stock | |
| Kiora Pharma Inc | Brian M. Strem | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) |